SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Manylion Llyfryddiaeth
Prif Awdur:	Meem, Manila
Awduron Eraill:	Akter, Dr. Raushanara
Fformat:	Traethawd Ymchwil
Iaith:	English
Cyhoeddwyd:	Brac University 2023
Pynciau:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Mynediad Ar-lein:	http://hdl.handle.net/10361/18081

Eitemau Tebyg

A review on potential of PARP inhibitors in the treatment of prostate cancer
gan: Islam, Saidul
Cyhoeddwyd: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
gan: Jahan, Nusrat
Cyhoeddwyd: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
gan: Flora, Sanzida Alam
Cyhoeddwyd: (2024)

Immunotherapy in the Management of Lung Cancer
gan: Tasnim, Humayra
Cyhoeddwyd: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
gan: Ratu, Tabassum
Cyhoeddwyd: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
gan: Emon, Kamrul Hasan
Cyhoeddwyd: (2022)

Identification of FAP inhibitors using in silico simulation study
gan: Deeba, Maliha Tasnim
Cyhoeddwyd: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
gan: Oshin, Sadia Afrin
Cyhoeddwyd: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
gan: Karim, Azrin
Cyhoeddwyd: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
gan: Mirza, Maisa Tasnim
Cyhoeddwyd: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
gan: Khan, Muidul Hasan
Cyhoeddwyd: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
gan: Haque, Mushfiqul
Cyhoeddwyd: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
gan: Islam, Nahidul
Cyhoeddwyd: (2023)

A review on targeted therapies for lung cancer
gan: Ashraf, Anushey
Cyhoeddwyd: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
gan: Afroza, Halima
Cyhoeddwyd: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
gan: Ishrat, Nowshin
Cyhoeddwyd: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
gan: Sorno, Rubina Haque
Cyhoeddwyd: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
gan: Mahin, Md. Tamjidur Rahman
Cyhoeddwyd: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
gan: Alam, Kazi Tasnuva
Cyhoeddwyd: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
gan: Fred, Namanda Rogers
Cyhoeddwyd: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
gan: Khandker, Tahia Anjum
Cyhoeddwyd: (2024)

Synthesis and sar o acne medication
gan: Naureen, Tasnia
Cyhoeddwyd: (2024)

HPLC method development for the analysis of linagliptin
gan: Mimiya, Ruhani Amrin
Cyhoeddwyd: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
gan: Paul, Pulock
Cyhoeddwyd: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
gan: Kamal, Tasnova
Cyhoeddwyd: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
gan: Tania, Umme
Cyhoeddwyd: (2023)

Trend in approval of targeted biologics in the last two decades
gan: Siddika, Khadiza
Cyhoeddwyd: (2024)

Breast cancer therapy through Liposomal drug delivery system
gan: Ome, Nusrat Jahan
Cyhoeddwyd: (2024)

Epigenetic therapy in cancer
gan: Abid, Md. Shadman Ridwan
Cyhoeddwyd: (2021)

A review on triple-negative breast cancer and its potential treatment
gan: Niasa, Jannatul Ferdous
Cyhoeddwyd: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
gan: Razna, Amrin Islam
Cyhoeddwyd: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
gan: Chakraborty, Anuradha
Cyhoeddwyd: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
gan: Nahar, Kamrun
Cyhoeddwyd: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
gan: Nashrah, Zannatul
Cyhoeddwyd: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
gan: Hoque, Syeda Mehren
Cyhoeddwyd: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
gan: Parvez, Safi
Cyhoeddwyd: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
gan: Sarkar, Onusree
Cyhoeddwyd: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
gan: Hasan, Amit
Cyhoeddwyd: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
gan: Dowla, Rumana, et al.
Cyhoeddwyd: (2022)